STING1 and neoplasm: However, in the treatment of some tumors, the rational use of inhibitors to inhibit the cleavage activity of endo/exonucleases can cause genomic instability in tumor cells, thereby activating the cGAS-STING pathway and enhancing the efficacy of immunotherapy.